HOUSTON, November 6, 2006 – Omega Protein Corporation (NYSE symbol: OME), the nation’s leading producer of Omega-3 fish oil and specialty fish meal products, today reported net income of $1.8 million (7 cents a share) for the third quarter of 2006, compared with a net loss of $6.1 million (25 cents a share) for the third quarter of the previous year.
Revenues for the third quarter ended September 30, 2006 were $52.1 million compared with revenues of $31.4 million for the comparable quarter in 2005. Omega Protein recorded operating income of $3.0 million for the 2006 third quarter, versus operating loss of $9.2 million for the third quarter of 2005.
For the nine months ended September 30, 2006, the Company had revenues of $113.7 million, compared with $82.8 million in revenues for the first nine months of 2005. Omega Protein recorded operating income of $7.8 million for the nine months ended September 30, 2006, versus operating loss of $8.2 million for the comparable period a year earlier. The Company had net income of $5.0 million (20 cents a share) for the nine months ended September 30, 2006, compared with net loss of $5.4 million (22 cents a share) for the nine months ended September 30, 2005.
The losses reported for the previous periods presented were attributable to the direct impact of two hurricanes on the Company’s facilities and operations in August and September of 2005. All of the Company’s Gulf of Mexico operations were impacted in 2005 and, to some extent, diminished capabilities carried forward into 2006. The Company’s third quarter results, as well as the results for the nine months ended September 30, 2006, are the result of higher sales prices and increased sales volumes, offset by higher costs of sales. The higher costs of sales were attributable to increased energy costs, higher repair costs and poor fish oil production yields.
Subsequent to the closing of the third quarter, the Company and Abelco Finance, LLC, an affiliate of Cerberus Capital Management, L.P., and Wachovia Bank, entered into a $65 million secured financing facility. The financing facility consists of a five year revolving credit facility of up to $30 million and a five year term loan facility of $35 million. The financing facility replaced the Company’s existing $20 million former bank credit facility.
The financing facility will be used to close the previously announced acquisition from Zapata of 9,268,292 shares of Omega’s common stock held by Zapata (the “Zapata Shares”) for an aggregate purchase price of $47.5 million, (ii) to fund the Company’s ongoing working capital and other general corporate requirements and (iii) to pay the fees and expenses related to the financing. On October 20, 2006, the Company drew down the $35 million term loan and approximately $13.6 million of revolving loans and funded into escrow the $47.5 million purchase price for the Zapata Shares.
In connection with Omega’s purchase of the Zapata Shares, Zapata has filed its definitive Information Statement relating to that transaction with the SEC and commenced the mailing to its stockholders on or about November 6, 2006. The closing of the transaction is expected in late November, subject to Omega’s receipt of a bring-down solvency opinion from its financial advisor and the satisfaction of additional customary closing conditions.
About Omega Protein
Omega Protein Corporation is the nation’s largest manufacturer of heart-healthy fish oils containing Omega-3 fatty acids for human consumption, as well as specialty fish meals and fish oil used as value-added ingredients in aquaculture, swine and other livestock feeds. Omega Protein makes its products from menhaden, an Omega-3 rich fish that is not utilized as seafood, but which is abundantly available along the U.S. Gulf of Mexico and Atlantic Coasts.
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS: The statements contained in this press release that are not historical facts are forward-looking statements that involve a number of risks and uncertainties. The actual results of future events described in any of these forward-looking statements could differ materially from those stated in the forward-looking statements. Important factors that could cause actual results to be materially different from those forward-looking statements include, among others, (1) the possibility that the Company’s estimates and assumptions for its calculation of hurricane losses could be incorrect; (2) the Company’s ability to meet its raw material requirements through its annual menhaden harvest, which is subject to fluctuations due to natural conditions over which the Company has no control, such as varying fish population, fish oil yields, adverse weather conditions and disease; (3) the impact of worldwide supply and demand relationships on prices for the Company’s products; (4) Omega Protein’s expectations regarding demand for OmegaPure® proving to be incorrect; and (5) fluctuations in the Company’s quarterly operating results due to the seasonality of the Company’s business and its deferral of inventory sales based on worldwide prices for competing products. These and other factors are described in further detail in Omega’s filings with the Securities and Exchange Commission, including its 2005 Annual Report on Form 10K under the headings, “Management’s Discussion and Analysis of Financial Condition” and “Risk Factors.”
Contact: Investor Relations Department (713) 623-0060
or hq@omegahouston.com
OMEGA PROTEIN CORPORATION
Statement of Operations
(Unaudited)
| |
Three Months
Ended Sept 30, |
|
Six Months
Ended Sept 30, |
| |
2006 |
|
2005 |
|
2006 |
|
2005 |
| |
(in thousands, except per share amounts) |
| Revenues |
$52,089 |
|
$31,418 |
|
$113,730 |
|
$82,759 |
| Cost of sales |
44,748 |
|
24,032 |
|
94,061 |
|
68,500 |
| Gross profit |
7,341 |
|
7,386 |
|
19,669 |
|
14,259 |
Selling, general, and administrative expense |
3,467 |
|
3,365 |
|
10,444 |
|
9,100 |
| Loss resulting from natural disasters |
918 |
|
13,183 |
|
1,351 |
|
13,183 |
| Loss on disposal of assets |
-- |
|
39 |
|
29 |
|
135 |
| Operating income |
2,956 |
|
(9,201) |
|
7,845 |
|
(8,159) |
| Interest (expense), net |
(398) |
|
(232) |
|
(1,043) |
|
(407) |
| Other income (expense) net |
(33) |
|
(66) |
|
(159) |
|
125 |
| Income before income taxes |
2,525 |
|
(9,499) |
|
6,643 |
|
(8,441) |
| Provision for income taxes |
713 |
|
(3,359) |
|
1,675 |
|
(3,067) |
| Net income |
$1,812 |
|
$(6,140) |
|
$4,968 |
|
$(5,374) |
| Basic earnings per share |
$0.07 |
|
$(0.25) |
|
$0.20 |
|
$(0.22) |
| Weighted average common shares outstanding |
25,153 |
|
24,997 |
|
25,095 |
|
24,957 |
| Diluted earnings per share |
$0.07 |
|
$(0.25) |
|
$0.19 |
|
$(0.22) |
Weighted average common shares and common share equivalents outstanding |
26,083 |
|
24,997 |
|
26,053 |
|
24,957 |
OMEGA PROTEIN CORPORATION CONDENSED BALANCE SHEET (Unaudited)
| |
June 30, 2006 |
|
December 31, 2005 |
| |
(in thousands) |
| ASSETS |
|
|
|
| Current assets |
$97,190 |
|
$98,390 |
|
| Property and equipment, net |
101,071 |
|
93,965 |
|
| Deferred tax assets, net |
4,838 |
|
6,293 |
|
| Other assets |
10,703 |
|
1,579 |
|
| Total Assets |
$213,802 |
|
$200,227 |
|
| LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
|
| Current liabilities |
$30,150 |
|
$19,270 |
|
| Long-term debt, less current maturities |
25,823 |
|
27,658 |
|
| Other long-term liabilities |
9,492 |
|
10,932 |
|
| Stockhoders' equity |
148,337 |
|
142,367 |
|
| Total liabilities and stockholders' equity |
$213,802 |
|
$200,227 |
|
| Book value per share outstanding |
$5.87 |
|
$5.69 |
|
|